{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:54:38Z","timestamp":1789901678077,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2012AA02A401"],"award-info":[{"award-number":["2012AA02A401"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.virusres.2014.07.017","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T20:20:58Z","timestamp":1406924458000},"page":"10-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone"],"prefix":"10.1016","volume":"191","author":[{"given":"Zhushi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.virusres.2014.07.017_bib0005","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2014.07.017_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2334-11-106","article-title":"Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries","volume":"11","author":"Barniol","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2014.07.017_bib0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1128\/JVI.6.4.500-506.1970","article-title":"Dengue virions and antigens in brain and serum of infected mice","volume":"6","author":"Brandt","year":"1970","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2014.07.017_bib0020","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/JVI.01950-10","article-title":"FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication","volume":"85","author":"Chien","year":"2011","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virusres.2014.07.017_bib0025","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.vaccine.2010.01.022","article-title":"Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys","volume":"28","author":"Clements","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virusres.2014.07.017_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2014.07.017_bib0035","doi-asserted-by":"crossref","first-page":"e25685","DOI":"10.1371\/journal.pone.0025685","article-title":"Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines","volume":"6","author":"Costa","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.virusres.2014.07.017_bib0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.virusres.2014.07.017_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tra.12012","article-title":"Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans","volume":"14","author":"Flipse","year":"2012","journal-title":"Traffic"},{"issue":"2","key":"10.1016\/j.virusres.2014.07.017_bib0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0966-842X(01)02288-0","article-title":"Epidemic dengue\/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century","volume":"10","author":"Gubler","year":"2002","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.virusres.2014.07.017_bib0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.2012.12-0157","article-title":"The economic burden of dengue","volume":"86","author":"Gubler","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"16","key":"10.1016\/j.virusres.2014.07.017_bib0060","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2014.07.017_bib0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/viro.2002.1462","article-title":"Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates","volume":"298","author":"Guirakhoo","year":"2002","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virusres.2014.07.017_bib0070","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2014.07.017_bib0075","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J. Virol."},{"issue":"42","key":"10.1016\/j.virusres.2014.07.017_bib0080","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"issue":"4839","key":"10.1016\/j.virusres.2014.07.017_bib0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenge to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.virusres.2014.07.017_bib0090","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virusres.2014.07.017_bib0095","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4269\/ajtmh.2006.75.986","article-title":"Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand","volume":"75","author":"Higgs","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.virusres.2014.07.017_bib0100","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JVI.74.7.3020-3028.2000","article-title":"Chimeric dengue type 2 (vaccine strain PDK-53)\/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine","volume":"74","author":"Huang","year":"2000","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2014.07.017_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2004.70.89","article-title":"Analysis of the replication kinetics of the ChimeriVax-DEN 1,2,3,4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction","volume":"70","author":"Johnson","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.virusres.2014.07.017_bib0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11262-011-0685-6","article-title":"Identification and characterization of the short variable region of the Japanese encephalitis virus 3\u2032 NTR","volume":"44","author":"Kato","year":"2012","journal-title":"Virus Genes"},{"issue":"21","key":"10.1016\/j.virusres.2014.07.017_bib0115","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.1128\/JVI.00846-11","article-title":"Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA","volume":"85","author":"Katoh","year":"2011","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2014.07.017_bib0120","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1128\/JVI.67.11.6567-6575.1993","article-title":"Genetic determinants of dengue type 4 virus neurovirulence for mice","volume":"67","author":"Kawano","year":"1993","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2014.07.017_bib0125","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/acr.22021","article-title":"Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study","volume":"65","author":"Kern\u00e9is","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"Suppl. 2","key":"10.1016\/j.virusres.2014.07.017_bib0130","first-page":"S20L 24","article-title":"Recent progress on Sanofi Pasteur's dengue vaccine candidate","volume":"46","author":"Lang","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2014.07.017_bib0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1348-0421.12140","article-title":"Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus","volume":"58","author":"Lazo","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"24","key":"10.1016\/j.virusres.2014.07.017_bib0140","doi-asserted-by":"crossref","first-page":"13694","DOI":"10.1128\/JVI.00931-13","article-title":"A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates","volume":"87","author":"Li","year":"2013","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2014.07.017_bib0145","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.70.6.3930-3937.1996","article-title":"Dengue type 4 virus mutants containing deletions in the 3\u2032 noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys","volume":"70","author":"Men","year":"1996","journal-title":"J. Virol."},{"issue":"15\u201316","key":"10.1016\/j.virusres.2014.07.017_bib0150","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monat","year":"1999","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.virusres.2014.07.017_bib0155","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2014.07.017_bib0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2014.07.017_bib0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"49","key":"10.1016\/j.virusres.2014.07.017_bib0170","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.vaccine.2013.09.030","article-title":"Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review","volume":"31","author":"Rafferty","year":"2013","journal-title":"Vaccine"},{"issue":"9853","key":"10.1016\/j.virusres.2014.07.017_bib0175","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.virusres.2014.07.017_bib0180","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3201\/eid1710.101789","article-title":"Yellow fever virus vaccine-associated deaths in young women","volume":"17","author":"Seligman","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"15","key":"10.1016\/j.virusres.2014.07.017_bib0185","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.virusres.2014.07.017_bib0190","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/QCO.0b013e32834a1b0b","article-title":"Critical issues in dengue vaccine development","volume":"24","author":"Thomas","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2014.07.017_bib0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/dna.2010.1114","article-title":"La protein can simultaneously bind to both 3\u2032- and 5\u2032-noncoding regions of Japanese encephalitis virus genome","volume":"30","author":"Vashist","year":"2011","journal-title":"DNA Cell Biol."},{"issue":"2","key":"10.1016\/j.virusres.2014.07.017_bib0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.2006.75.333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.virusres.2014.07.017_bib0205","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"issue":"19","key":"10.1016\/j.virusres.2014.07.017_bib0210","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.00512-07","article-title":"An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice","volume":"81","author":"White","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2014.07.017_bib0215","series-title":"Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control","author":"WHO","year":"1997"},{"key":"10.1016\/j.virusres.2014.07.017_bib0220","series-title":"Dengue Guidelines for Diagnosis, Treatment, Prevention and Control","author":"WHO","year":"2009"},{"key":"10.1016\/j.virusres.2014.07.017_bib0225","series-title":"Guidelines for Plaque Reduction Neutralization Testing of Human Antibodies to Dengue Viruses","author":"WHO","year":"2007"},{"key":"10.1016\/j.virusres.2014.07.017_bib0235","series-title":"Recommendations to Assure the Quality, Safety and Efficacy of Japanese Encephalitis Vaccines (Live, Attenuated) for Human Use","author":"WHO","year":"2012"},{"key":"10.1016\/j.virusres.2014.07.017_bib0230","series-title":"Recommendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks. Replacement of Annex 1, TRS, 878. Technical Report Series 978, Annex 3","author":"WHO","year":"2013"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170214002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170214002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T21:08:33Z","timestamp":1598130513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170214002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":47,"alternative-id":["S0168170214002834"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2014.07.017","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2014.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}